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Abstract
Guanine-nucleotide dissociation inhibitors (GDI) are negative regulators of Rho family GTPases 
that sequester the GTPases away from the membrane. Here we ask how GDI-Cdc42 interaction 
regulates localized Cdc42 activation for cell motility. The sensitivity of cells to overexpression of 
Rho family pathway components led us to a new biosensor design (GDI.Cdc42 FLARE), in which 
Cdc42 was modified with a FRET ‘binding antenna’ that selectively reported Cdc42 binding to 
endogenous GDI. Similar antennae could also report GDI-Rac1 and GDI-RhoA interaction. 
Through computational multiplexing and simultaneous imaging, we determined the spatiotemporal 
dynamics of GDI-Cdc42 interaction and Cdc42 activation during cell protrusion and retraction. 
This revealed a remarkably tight coordination of GTPase release and activation on a time scale of 
10 seconds, suggesting that GDI-Cdc42 interactions are a critical component in the spatiotemporal 
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regulation of Cdc42 activity, and not merely a mechanism for global sequestration of an 
inactivated pool of signaling molecules.
Introduction
Rho GTPases are critical in numerous cell functions but especially well characterized in the 
regulation of cytoskeletal dynamics1-3. GTPases are activated via binding of a GTP 
nucleotide and deactivated via hydrolysis of GTP to GDP. Molecular mechanisms and 
effector pathways have been determined through structural analysis, biochemical approaches 
and imaging. However, only through implementation of biosensors that report GTPase 
activity in situ has it become clear that GTPase cycles are modulated on length and time 
scales of single microns and seconds 4-9.
Three families of regulatory proteins modulate Rho GTPase activity: Guanine-nucleotide 
exchange factors (GEFs) facilitate removal of GDP and binding of GTP, and GTPase 
activating proteins (GAPs) accelerate the hydrolysis of bound GTP to GDP. Guanine-
nucleotide dissociation inhibitors (GDI) sterically block effector interactions, and extract 
GTPases from the membrane to prevent activation by GEFs. More than 80 GEFs and GAPs 
act on Rho GTPases10. This diversity confers specificity, enabling a wide variety of input 
signals to generate different cell behaviors via a relatively smaller number of Rho GTPases 
(22 Rho family members in mammals, of which Cdc42, Rac1, and RhoA have been most 
prominently implicated in cytoskeletal regulation). Initial evidence using GTPase biosensors 
and other approaches suggests that GEFs and GAPs generate this wide variety of cell 
behaviors by controlling the location and kinetics of GTPase activation.
In contrast to the GEFs and GAPs, there are only three genes encoding RhoGDIs, and each 
of their protein products interacts with several GTPases. Among them, RhoGDI1 (or 
RhoGDIα, henceforth referred to simply as GDI) is the most abundant and ubiquitously 
expressed isoform, and it interacts with all three canonical GTPases. Accordingly, it has 
been assumed that GDI-GTPase interactions were less specific and less spatially regulated, 
functioning primarily to provide a uniform cytosolic pool of inactive GTPases that can be 
accessed by localized regulatory proteins. However, some studies suggested that there is a 
certain degree of spatiotemporal regulation of GDI-GTPase interactions, mediated by 
lipids11-13 and kinases that control GDI-GTPase affinity by phosphorylating RhoGDI14-17 or 
the GTPase18-21. Therefore, it is plausible that modulation of GDI-GTPase interactions also 
contributes to the fine-tuned spatiotemporal organization of Rho GTPase signaling.
To address the question of how much GDI-GTPase interactions contribute to the regulation 
of GTPase activity, we focused on developing biosensors that could report the localization 
and concentration of GDI-GTPase complexes in living cells. We developed a new biosensor 
design based on a ‘binding antenna’, a single chain containing two fluorescent proteins 
(FPs) attached to the GTPase of interest. The fluorescence resonance energy transfer (FRET) 
efficiency of the binding antenna was altered when GDI bound to the GTPase. An important 
advantage of this design was its ability to reduce the need to introduce exogenous protein. 
The biosensor reports interaction between modified Cdc42 and endogenous GDI. With the 
GDI-GTPase biosensor, we explored changes in the distribution of GDI-Cdc42 complex 
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during motility. Far from being a uniform reservoir of inactive GTPase, the GDI-GTPase 
complex concentrated in protrusions at precise times and positions relative to edge 
movement and to nearby Cdc42 activation. To test how GDI-Cdc42 complex formation 
affects Cdc42 activation we modified our existing dye-based biosensor of Cdc42 activity 
(meroCBD) 6 and imaged GDI-Cdc42 interaction and Cdc42 activity concurrently in the 
same cell. This paper presents the first spatiotemporally resolved map of GDI-mediated 
Cdc42 regulation.
Results
A fluorescent biosensor of GDI-Cdc42 binding
The design of the new GDI-Cdc42 interaction biosensor stemmed from biosensor 
optimization studies in which we discovered that FRET between two FPs attached to the N 
terminus of Cdc42 responded strongly to interaction with wild type, “unlabeled” GDI (Fig. 
1a). The “binding antenna” attached to Cdc42's N terminus consisted of monomeric 
Cerulean (mCer)22, attached via an optimized short linker to circularly permutated Venus 
(cpVen)23. The mCer contained an A206K mutation to reduce interactions between the 
FPs 24. By optimizing the antenna structure using different linkers and circular permutants 
(see Supplementary Results, Supplementary Fig. 1), we were able to generate a structure 
that effectively responded to GDI, but not to GEFs, GAPs or Cdc42 effectors. GTPases 
require post-translational modification with a lipid moiety at the C-terminus for GDI binding 
(the lipid binds to the immunoglobulin-like β sandwich of the GDI) 25. Thus, to maintain 
normal GDI functions it was essential to keep the GTPase C-terminus intact. We named the 
new biosensor GDI.Cdc42 FLARE. Although we focused here on Cdc42-GDI interactions, 
we also produced biosensors for Rac1- and RhoA-GDI interactions (see Supplementary 
Fig. 1&2); biological studies with these will be pursued in the future.
We assayed the specificity and fluorescence response of the biosensor by obtaining 
fluorescence spectra of biosensor mutants co-expressed with different Cdc42 upstream 
regulators in suspensions of HEK293T cells. Using increasing ratios of regulator to 
biosensor cDNA revealed plateaus in fluorescence change, indicating where binding and the 
resulting effects on fluorescence saturated, similar to previously results 5. We observed a 
218% increase in FRET/CFP emission ratio when we increased GDI from no expression to a 
4:1 GDI:biosensor cDNA ratio. Figures 1b and 1c show the fluorescence of the biosensor 
and its mutants with or without excess-GDI co-expression. Only mutants capable of binding 
to GDI showed effects of GDI co-expression. The R66E mutant, deficient in GDI-binding, 
showed no change in FRET with or without the excess-GDI. The D118 mutant, unable to 
release GEFs, showed no fluorescence change with or without excess-GDI, indicating that 
the biosensor did not respond to GEF binding. This mutation also prevented response to 
GDI, consistent with previous data indicating competition between GEFs and GDI for the 
same binding regions on GTPases 2,10. Effector binding did not affect FRET, as the T35S 
mutant, which blocks effector binding26,27, did not alter response to GDI. Furthermore, there 
was no response to either co-expressed GEFs or to downstream effectors (see 
Supplementary Fig. 3a&b).
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The co-expression of exogenous, activated GEFs abrogated FRET response to excess GDI 
(Fig. 1d), but only for GEFs that affect Cdc42 (the RhoA GEF Ect2 does not bind Cdc42). 
Reduction of the FRET response caused by 4-fold excess-GDI required a 4-fold excess of 
GEF over biosensor cDNA, consistent with GEF-Cdc42 affinities and previously published 
results 5. Excess GEFs alone had no effect on biosensor fluorescence, nor did GAPs (Fig. 
1d). For studies in Figure 1d we used constitutively active DH-PH fragments of GEFs. 
Similar results were obtained with full-length GEFs (see Supplementary Fig. 3a&b), using 
T17N and D118A Cdc42 mutants that are known to tightly sequester GEFs 28.
The biosensor's remarkable selectivity for GDI is consistent with published crystal 
structures. The cp49Ven FP extends from Cdc42 at a position that is not part of the known 
binding sites for GEFs, GAPs, GDI or effectors (see Supplementary Fig. 4). There was 
almost no FRET when the biosensor was free of GDI, as indicated by biosensor FRET with 
and without GDI co-expression (Fig. 1b), and by the dependence of FRET on intracellular 
concentration (see Supplementary Fig. 5a; biosensor FRET plateaued at a low value when 
increasing expression level reduced binding to endogenous GDI). Low FRET was not due to 
proteolysis, as shown by gel electrophoresis (see Supplementary Fig. 5b). The low FRET 
in the GDI-free state indicated that the two FPs adopted a relatively fixed conformation, 
where their distance and/or orientation produced little FRET. The two FPs could be in a low 
FRET conformation due to steric and torsional factors, or because mCer bound to a portion 
of the Cdc42 surface accessible only when the sensor was GDI-free (see Supplementary 
Fig. 4). mCer may interact with the region where GDI binds to the C terminal tail of Cdc42, 
and where GEFs, GAPs and effectors do not bind. FRET increased upon GDI binding, but 
this FRET diminished when we reduced interactions between the FPs by adding an A206K 
mutation24 into cpVenus (see Supplementary Fig. 5c). This suggested that interactions 
between the FPs enhanced FRET in the GDI-bound state. Interaction of the FPs with GDI 
may also induce a high FRET conformation.
Dynamics of the GDI-Cdc42 complex in cell protrusions
We stably expressed the GDI.Cdc42 FLARE biosensor in mouse embryonic fibroblasts 
(MEF/3T3) under control of a tetracycline-inducible promoter (tet-OFF) as described 
previously 5. The cells were sensitive to overexpression of the biosensor, as they are to 
overexpression of Cdc42 6. We therefore established stable, inducible cells with expression 
levels below those producing effects on cell morphology or motile behavior (see 
Supplementary Fig. 6). The biosensor showed elevated binding of GDI to Cdc42 
throughout most of the cell body, but cell edges showed reduced FRET/donor ratio, 
indicating that the majority of the GDI-Cdc42 complex occupied the bulk cytosolic space in 
the cell body (Fig. 2a). Live-cell imaging of the GDI-Cdc42 complex revealed a strikingly 
dynamic behavior at the cell edge during protrusion/retraction cycles (Fig. 2b; see 
Supplementary Videos 1-4). Linescans perpendicular to the cell edge showed reduced 
FRET ratios within 2 μm of the edge during protrusion, whereas the ratio elevated during 
retraction, with the highest values associated with ruffles undergoing retrograde movement 
(Fig.2b). This indicated a reduced GDI-Cdc42 complex specifically at the edge during 
protrusion, and concentrated in rearward moving ruffles during retraction. The ruffles 
showed reduction in GDI-Cdc42 complex on the side distal from the edge.
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To investigate the dynamics of GDI-Cdc42 binding more quantitatively we utilized cross-
correlation between the FRET/donor ratio and cell edge motion, as used previously to 
analyze coupling of GTPase activities with cell edge velocity4. We first verified that the 
average period of protrusion-retraction cycles in the wild type and GDI.Cdc42 FLARE 
(wildtype) biosensor cells were statistically indistinguishable (see Supplementary Fig. 6). 
This confirmed that expressing the biosensor did not perturb the regulation of basal 
protrusion-retraction cycles. Consistent with the linescan analysis in Figure 2b, the coupling 
between GDI-Cdc42 and edge motion in sampling windows sub-adjacent to the leading edge 
(0–0.9 μm) showed a significant negative cross-correlation (–0.203 ±0.034) at –2s ±13s time 
lag (Fig. 2c). This suggested that overall GDI-Cdc42 binding reduced concurrently with 
edge protrusion and increased during retraction. The strength of this negative correlation 
increased at the next sampling window position (0.9–1.8 μm from the edge), while the 
negative time lag also increased to significant values (–20s ±9s). This indicated that the 
modulation of GDI-Cdc42 interaction slightly lagged the modulation of edge velocity. In 
sampling windows even further away from the edge, a significant positive cross-correlation 
peak appeared at +42 ±23s. The strength of this positive peak increased with the distance to 
the cell edge, indicating increased GDI-Cdc42 binding prior to protrusion and/or GDI-
Cdc42 release prior to retraction. Together these analyses revealed distinct, fine-tuned 
regulation of GDI-Cdc42 binding for different regions at the cell edge.
Next, we wished to understand GDI-Cdc42 dynamics relative to Cdc42 activation. We 
decided to approach this first by computational multiplexing (see Supplementary Fig. 7), in 
which we measured the kinetics of biosensor activities in separate cells and determined their 
relationship to cell edge motion, which was used as a common fiduciary4. As previously 
published6, we monitored Cdc42 activity in wildtype MEFs using meroCBD. Consistent 
with our previous analyses4, we found significant correlation between Cdc42 activation and 
edge velocity at a time lag of –46s ±31s (Fig. 2c) indicating a delayed Cdc42 activation 
relative to cell protrusion. Also consistent with our previous findings, the correlation 
between edge velocity and Cdc42 activity was maximal in the window row 0.9 – 1.8 μm 
from the cell edge, suggesting that Cdc42 likely activated at the location of mature focal 
adhesions, which were, on average, 2–3 μm back from the cell edge (Fig. 2c). Beyond the 
second row of windows, the correlation strength decreased. Qualitatively, these Cdc42 
activation characteristics matched well with our observation of a negative correlation peak 
between edge motion and GDI-Cdc42 interaction at –20s to –40s. This suggested that the 
negative correlation between edge motion and GDI-Cdc42 binding predominantly associated 
with a release of Cdc42 from GDI shortly after protrusion onset. To confirm this relationship 
more systematically we computed the cross-correlation between two correlation functions: 
velocity to GDI-Cdc42 interaction (using GDI.Cdc42 FLARE) and velocity to Cdc42 
activity (using meroCBD) (Fig. 2c). As expected, these two functions correlated strongly 
and negatively, with a time lag of ~45s at the leading edge (0–0.9 μm); i.e. the reduction in 
GDI-Cdc42 interaction preceded the activation of the Cdc42 signal by ~45s. In locations 
further away from the edge, the strength of negative cross-correlation increased while the 
time lag converged to zero or even slightly positive values. This suggested a reduction in 
time between Cdc42 release and activation with greater distance from the cell edge. 
However, we could not quantify the exact reduction in time lag as the positive lobe in the 
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velocity to GDI-Cdc42 interaction correlation function at positive lag times biased the 
position of the cross-correlation minimum. Overall, these results showed that the new 
GDI.Cdc42 FLARE biosensor reported signals that were tightly coordinated with the 
activation of Cdc42 and the relationship between GDI-Cdc42 complex localization and 
Cdc42 activation.
Re-engineering a Cdc42 biosensor for multiplexed imaging
To analyze the relations between localization of the GDI-Cdc42 complex and Cdc42 
activation more directly, we strived for concurrent imaging of both events in the same cell. 
Our previously described meroCBD biosensor 6 was based on a fragment of the Wiskott 
Aldrich Syndrome Protein (WASP) that binds selectively to active Cdc42. We covalently 
derivatized this fragment with mero87, a dye whose fluorescence responds to changes in 
solvent environment 29. Dye fluorescence increased when the WASP fragment bound active 
Cdc42, revealing Cdc42 activation dynamics. Enhanced green fluorescent protein (eGFP) 
was attached to this biosensor to enable “ratio imaging”, a technique for eliminating effects 
of cell morphology, biosensor concentration, or uneven illumination on biosensor readouts6. 
eGFP wavelengths overlap those of the GDI.Cdc42 FLARE biosensor, so for the current 
study we replaced eGFP with maltose binding protein (a nonfluorescent protein that 
enhances water solubility as does eGFP) and site-specifically labeled the biosensor with 
Atto-700 dye for ratio imaging (taking advantage of selective deprotonation of the WASP 
fragment N-terminus at pH 5.2, see Supplementary Fig. 8a). We attached the mero87 
dye 6,29 selectively to a cysteine inserted at position 271 in the WASP fragment 6, using a 
cysteine-selective iodoacetamido derivative (neither the maltose binding protein nor the 
WASP domain had other exposed cysteines). The two dyes attached with a 1:1 ratio and 
labeling efficiencies of >95% .
The mero87 dye on the new meroCBD biosensor showed a 325% increase in fluorescence 
upon binding to Cdc42 (see Supplementary Fig. 8b). The Atto-700 emission at 705 nm 
also increased by 162%, enabling ratiometric measurements of Cdc42 activation (change in 
ratio of mero87/Atto700 emission = 200%). The 705 nm emission of the Atto dye not only 
eliminated bleed-through into the CFP-YFP FRET channels, but was also compatible with 
the laser-autofocus systems used in several commercial imaging systems. The Atto-700 dye 
showed photostability superior to other dyes used previously (see Supplementary Fig. 8c).
Dynamics of Cdc42 activation and GDI-Cdc42 localization
To study the relative dynamics of Cdc42 activation and the localization of Cdc42-GDI 
complex in the same cell, we microinjected the modified meroCBD biosensor into Swiss 
3T3 mouse embryonic fibroblasts (MEF) stably expressing the GDI.Cdc42 FLARE 
biosensor. Although each biosensor could be used at effective concentrations without 
altering motility 6, we observed effects on cell morphology and reduced adhesion when we 
used similar concentrations of the two biosensors 26,27. At concentrations where we 
observed no perturbation, low signal/noise precluded correlation analysis. Therefore, we 
included a T35S mutation in the GDI.Cdc42 FLARE biosensor to reduce effector binding 
and enable use of higher biosensor concentrations without changing cell behavior. This 
mutation could potentially generate dominant negative effects, so we stably expressed the 
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T35S GDI.Cdc42 biosensor in mouse embryonic fibroblasts (MEF) under control of the tet-
OFF system30 and FACS-sorted the MEFs on the basis of GDI.Cdc42 FLARE brightness 
prior to injection. We determined brightness levels that did not perturb normal motile 
behavior or Cdc42 activation dynamics (see Supplementary Fig. 9).
The co-imaging of the T35S GDI.Cdc42 FLARE and meroCBD biosensors in living 
fibroblasts revealed a relatively homogenous distribution of low Cdc42 activity 
corresponding with elevated GDI-Cdc42 binding throughout most of the cell. This was 
consistent with the data generated by the wildtype sensor and with the notion of GDI 
maintaining a pool of inactive Cdc42 (Fig. 3a). Again, we observed transient and localized 
changes in the GDI-Cdc42 complex at the cell edge (Fig. 3a&b; see Supplementary Videos 
5-7), especially in regions with active retraction and protrusion. As with the wildtype 
GDI.Cdc42 FLARE sensor, cross-correlation of the T35S GDI.Cdc42 FLARE signal with 
cell edge velocity consistently displayed a negative peak in all window rows between 0–4 
μm (Fig. 3c), which likely associated with the release of Cdc42 from GDI during protrusion 
events. Data from wildtype and T35S mutant biosensors differed quantitatively, but not 
qualitatively, in the time lags of the peak, suggesting these two biosensors had somewhat 
different kinetics due to the influence of effector binding. Moreover, the mutant sensor did 
not produce a significant positive correlation peak with the velocity at positive time lags, 
neither at the cell edge nor further inside the cell (Fig. 3c&2c). Most probably, this 
secondary correlation peak disappeared because the absence of effector binding changed the 
dynamics of GDI-Cdc42 complex formation prior to protrusion events, or because the higher 
noise level masked more subtle secondary effects detected by the WT sensor.
Figure 3b displays Cdc42 activation and GDI-Cdc42 localization, observed by concurrent 
imaging of both FRET sensors during a representative episode of protrusion–retraction–
protrusion. As predicted by the computational multiplexing analysis using wildtype 
GDI.Cdc42 FLARE this data showed a strong reduction in Cdc42.GDI signal during 
protrusion. Moreover, reduction in Cdc42-GDI complex accompanied Cdc42 activation as 
reported by the reengineered meroCBD. During retraction, we observed the opposite signals: 
The Cdc42 activation dropped, whereas localized GDI-Cdc42 complex sharply increased. 
This suggested that GDI promptly and efficiently sequestered deactivated Cdc42 during 
retraction. The profiles in Figure 3b also showed that these inverse relations between Cdc42 
activity and GDI-Cdc42 binding concentrated to the very leading edge of a cell.
To quantify the coupling between Cdc42 activity and localization of the GDI-Cdc42 
complex, we again applied correlation analysis. With simultaneous imaging of both 
activities, we could for the first time map the spatial organization of the relationship between 
Cdc42 activation and GDI-Cdc42 complex formation. In sampling windows immediately 
adjacent to the cell edge, the correlation function displayed a significant negative peak with 
a time lag of approx. –20s, indicating that GDI released Cdc42 before Cdc42 activation (Fig. 
3d). Qualitatively, this time lag between release and activation of the GTPase matched the 
prediction of a GTPase activation delay by computational multiplexing (Fig. 2c). Also 
consistent between these two analyses was that the negative peaks of the correlation function 
moved to zero in sampling windows 0.9–1.8 μm and 1.8–2.7 μm from the cell edge. As 
before, this data is consistent with concentration of active Cdc42-GEFs a few μm behind the 
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cell edge, a proposition we made before based on the cross-correlation between Cdc42 
activities and velocity alone 4. Contrary to the predictions from the computational 
multiplexing suggesting a significant inverse relationship between Cdc42 activity and GDI-
Cdc42 localization in sampling windows 2.7–3.6 μm from the cell edge, correlation analysis 
from simultaneous imaging of the two biosensors indicated that GDI-Cdc42 binding lacked 
significant influence on the regulation of Cdc42 beyond a ~3 μm wide band from the cell 
edge. Again, this could be due to the elimination of effector binding in the mutant biosensor, 
but overall these analyses showed that in qualitative terms the mutated T35S GDI.Cdc42 
FLARE and the wildtype GDI.Cdc42 FLARE reported the same spatiotemporal 
coordination of GDI binding and GTPase activation, and that the antenna can be used 
together with dye-based biosensors for multiplexed imaging.
Src regulation of GDI-Cdc42 interaction
Equipped with tools to directly observe and quantify the relationships between GDI-Cdc42 
complex and Cdc42 activation we sought to validate and expand biochemical models of the 
regulation of GDI-GTPase interactions in the context of living cells. Previous biochemical 
studies show that phosphorylation of GDI by Src at Y156 largely abolishes GDI's affinity for 
Cdc42, Rac1 and RhoA 15. Moreover, this phosphorylation significantly impacts the ability 
of GDI to extract RhoA from isolated plasma membrane 15. Thus, Src may regulate the 
localization and timing of GDI-Cdc42 interactions during protrusion. To test this in living 
cells, we established an optimized knockdown/rescue procedure to replace endogenous GDI 
with either Y156F (phosphorylation-deficient) or Y156E (phosphomimetic) GDI, and 
examined the effects of these changes on the leading edge correlations (Fig. 4). Previously, 
Y156F GDI mutant shows cellular distribution and phenotype similar to the wildtype GDI, 
while Y156E GDI accumulates at the leading edge and within edge ruffles 15. While such 
accumulation was observed in fixed-cells, in vivo evidence for binding of this mutant GDI to 
Cdc42 at the edge ruffles in living cells remains elusive, especially in light of the severely 
abrogated affinity of the Y156E GDI mutant for GTPases 15. We used shRNA against 
endogenous GDI (see Supplementary Fig. 10) followed by stable, viral transduction with 
GDI mutants resistant to the shRNA.2,15,31 For these experiments we used the T35S 
GDI.Cdc42.FLARE biosensor to probe GDI-Cdc42 localization and imaged Cdc42 activity 
in separate cells to avoid overloading cells harboring GDI mutations with two biosensors 
(see Supplementary Videos 8–11). As expected, cross-correlations between edge motion 
and Cdc42 activity in cells with GDI Y156F were identical to those using wildtype GDI 
(Figs. 4a&2c). In contrast, GDI Y156E produced a small but measureable positive cross-
correlation between GDI-binding and edge motion at negative time lags for the first two 
window rows (Fig. 4b). From this observation, we concluded that at these locations the 
mutant GDI bound to the plasma membrane-localized Cdc42 and was thus confined within 
its activation compartment. Previous observations by immunofluorescence 15 shows an 
accumulation of theY156E GDI mutant in this region, supporting the notion that the reduced 
affinity of this GDI mutant for GTPase prevents transfer of the prenylated C-terminus of the 
GTPase out of the plasma membrane into the β-sandwich of the GDI structure. Hence, this 
mutation may prevent extraction of the GTPase from the plasma membrane. Our results here 
showed that a significant fraction of GDI actually bound and remained bound to Cdc42 at 
the edge, likely because of its reduced affinity. At distances further away from the cell edge 
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the correlation functions were qualitatively the same as those of the non-mutated biosensor 
(Fig. 4b). This indicated that activation of Cdc42 and localization of the Cdc42-Y156E GDI 
complex were concurrent/concomitant only within the edge region (0–1.8 μm). Furthermore, 
the formation of Cdc42-GDI complex and Cdc42 activation at those locations occurred with 
the same dynamics (Fig. 4b). Both lagged changes in protrusion velocity (Cdc42 (0–0.9 
μm): –87s ±47.5s; GDI-binding (0–0.9 μm): –67s ±28s; t-test between Cdc42 activation and 
GDI-binding at 0–0.9 μm: p=0.358425; Cdc42 (0.9–1.8 μm): −45s ±42.5s; GDI-binding 
(0.9–1.8 μm): –92s ±40.5s; t-test between Cdc42 activation and GDI-binding at 0.9–1.8 μm: 
p=0.21733). As in previous observations, the GDI Y156E mutant produced slightly faster 
leading edge turnover rates (see Supplementary Fig. 5) 15. Together, these data 
demonstrated that in living cells, phosphorylation of GDI at Y156 by Src did not regulate the 
ability of GDI to bind to GTPase but rather the ability of GDI to extract the GTPases from 
the plasma membrane.
Discussion
We described an approach to sense protein interaction in living cells by modifying only one 
of two interacting proteins. A ‘binding antenna’ was placed on Rho GTPases where its 
FRET was affected by GDI binding, but not by other ligands. Use of a binding antenna can 
substantially reduce cell perturbation because only one protein in an interacting pair needs 
modification. By attaching binding antennae to affinity reagents that interact selectively with 
activated target proteins (e.g. the WASP domain in the meroCBD biosensor used here) it 
should be possible to make genetically encoded biosensors that sense activation of 
endogenous proteins.
Through multiplexed imaging of GDI-Cdc42 interaction and Cdc42 activation, we 
determined the relative kinetics of these two events in the context of cell protrusions. We 
showed that localized buildups of Cdc42-GDI complex and Cdc42 activation were inversely 
related within protrusions. Mapping this relation revealed a remarkably tight coordination on 
a time scale of 10 seconds. This suggests that GDI-Cdc42 interactions are a critical 
component in the spatiotemporal regulation of Cdc42 activity, and not merely a mechanism 
for global sequestration of an inactive pool of GTPase. Extrapolating from the time scale of 
cell protrusion, regulation of GDI-Cdc42 interaction may in fact be rate-limiting in GTPase 
activation during this process: After release of signaling molecules into the plasma 
membrane, sufficient GEFs are already primed or rapidly activated to induce GDP to GTP 
exchange on a time scale of seconds. It would follow that the characteristic timing of Cdc42 
activation during protrusion events is at least in part mediated by localized release of 
GTPase from GDI. Indeed, the cross-correlation between appearance of the Cdc42-GDI 
complex and edge velocity shows a remarkably narrow spike over the time lag interval of 
~25s, suggesting that Cdc42 is released shortly after the protrusion edge velocity has 
reached maximal values. The resulting positive correlation of Cdc42 with velocity stretches 
over a 6-fold longer time lag interval. This observation is again consistent with a mechanism 
in which GEFs rapidly activate Cdc42 at the protruding cell edge, and activated molecules 
then diffuse over a broader region in which they remain active by repeated interactions with 
GEFs, or by diminished GAP activity. This example illustrates that understanding GTPase 
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signaling will require correlating the activity of GDI, GEFs and GAPs. With the present 
work, we have taken a first step in this direction.
Our spatiotemporal analysis of the GDI-Cdc42 complex also revealed precisely localized 
decreases in Cdc42-GDI complex concentrations. This was especially surprising for an 
interaction that has thus far been associated with global sequestration of GTPases. While 
several cues could modulate the interaction, our findings now add to this data the 
requirement that the cues themselves operate with precise localization and timing. As a 
proof of principle, we demonstrated here how the Cdc42-GDI interaction responded to Src-
kinase activity, impacting the ability of GDI to extract GTPase from the plasma membrane. 
We picked Src among the GDI-phosphorylating kinases because its activity is precisely 
coupled to the formation and force-mediated activation of adhesions 32,33, and because of its 
documented roles in activating GEFs 34. As other kinases could be specific for different 
GTPases 15-17,35, further investigation in this area using biosensors would be valuable.
In summary, our work proposes a hitherto unappreciated complexity in the regulation of Rho 
GTPase signaling activity. Besides the well-established roles of GEFs and GAPs as 
spatiotemporal sculptors of the GTPase signaling landscape, this study adds GDI 
interactions as an additional factor. The described biosensor provides a valuable means to 
dissect these regulatory mechanisms in the context of diverse cell functions, and the antenna 
readout mechanism provides a tool to examine protein-protein interactions with modification 
of only one interacting partner.
Online Methods
Biosensor expression constructs
The G/C FLARE biosensor was cloned by connecting a hexaHis tag, monomeric Cerulean 
fluorescent protein (FP) 22 and a circularly permutated (cp49) Venus FP 23. Monomeric 
Cerulean and cp49 Venus FPs were connected by an GSGS linker, which was flanked by 
HindIII and NotI restriction sites on the 5’ and 3’ ends, respectively. The construct was 
cloned into a pTriEX-HisMyc4 backbone (Novagen) at NcoI/EcoRI sites. RhoGTPases were 
cloned by polymerase chain reaction (PCR) using primer sets 5’-
CCAAGGAATTCATGGCTGCCATCCGGAAG-3’ and 5’-
GGTGATGGTGGTGCTCGAGTTATCACAAGAC-3’ for RhoA, 5’-
CAAGGAATTCATGCAGGCCATCAAGTGTGTGG-3’ and 5’-
GGTGATGGTGGTGCTCGAGTTATTACAACAGC-3’ for Rac1, and 5’-
CCCCCGGAATTCATGCAGACAATTAAGTGTG-3’ and 5’-
GGTGATGGTGGTGCTCGAGTTATCATAGCAG-3’ for Cdc42. Primers encoded an EcoRI 
site at the 5’ end of the fragment and an XhoI site after the stop codon on the 3’ end. They 
were inserted in frame at the C-terminus of the Antenna module in the pTriEx-HisMyc4 
backbone. The Quikchange mutagenesis kit (Stratagene) was used to introduce point 
mutations into the fragment encoding the GTPase, producing different mutant versions of 
the biosensor. To produce the tetracycline-inducible retroviral construct, the cDNA encoding 
the GDI biosensor was cut out as a single cassette using NcoI/XhoI sites, blunt-ended using 
an end-filling reaction using DNA Polymerase I Large (Klenow) fragment (New England 
Biologicals) and blunt-end ligated into the multiple cloning site at HpaI in the pBabe-sin-
Hodgson et al. Page 10
Nat Chem Biol. Author manuscript; available in PMC 2017 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Puro-tet-CMV backbone 36. The GP2-293 cell line (Clontech) was used to produce the 
pantropic retrovirus by cotransfecting the pVSVg vector (Clontech). Infected mouse 
embryonic fibroblasts which stably expressed the tetracycline transactivating element (tet-
OFF MEF/3T3; Clontech) were cultured in DMEM supplemented with 10% fetal bovine 
serum. They were selected for stable incorporation of the biosensor by puromycin treatment 
(10μg/ml), and FACS sorted to collect cell fractions expressing different levels of the 
biosensor. Doxycycline (10μg/ml) was maintained in the culture medium to repress the 
expression of biosensor during normal cell culture. 48hrs prior to imaging experiments, 
doxycycline was removed by detaching cells by brief trypsinization and replating into fresh 
culture medium at 10–4 cells per 10cm TC dish.
Western blot, reagents and antibodies
Whole cell lysates were prepared by lysing cells in ice-cold NP-40 lysis buffer (NaCl, 150 
mM, NP-40, 1.0%, Tris-Cl, 50 mM, pH 8.0) with protease inhibitor cocktail (Sigma). 
Lysates were resolved by SDS-PAGE and transferred to PVDF membrane. After blocking in 
5% BSA in TBST, blots were incubated overnight at 4°C in primary antibody at 1:1000 
dilution, followed by secondary antibody at 1:10000 dilution. Blots were analyzed using the 
Odyssey Infrared Imaging System (LI-COR). For quantification, the integrated values of 
background-corrected band densities were measured with Metamorph software (Molecular 
Devices). The following primary antibodies were used for the Western analysis and 
immunofluorescence (primary antibodies at 1:1000 dilution): mouse monoclonal anti-RhoA 
(Santacruz biotechnology), clone 26C4; mouse monoclonal anti-Rac1 (Millipore), clone 
23A8; rabbit polyclonal anti-Cdc42 (Millipore); rabbit polyclonal anti-GDI-α (Santacruz 
biotechnology) A-20; mouse monoclonal anti-β-actin (Santa Cruz biotechnology), clone 
AC-15; mouse monoclonal anti-HA (Covance), clone 16B12; mouse monoclonal anti-myc 
(Cell Signalling), clone 9B11; rabbit polyclonal anti Src pY418 (Invitrogen); mouse 
monoclonal anti-Src (Millipore), clone GD11; and mouse monoclonal anti-GFP (Roche) 
clone 7.1 and 13.1. Secondary antibodies (used at 1:10000 dilution): goat anti- mouse 
IRDye800CW and goat anti-rabbit IRDye800CW (Li-Cor); goat anti-mouse Alexa-594 
(Molecular Probes); and donkey anti-rabbit IRDye680LT (Li-Cor). Mammalian expression 
cDNA constructs for myc-WASP and HA-Tiam1 were gifts from Dr. Dianne Cox. Myc-
Intersectin1L was a gift from Dr. Henry Bourne. Myc-mDia2 was from Dr. Shuh Narumiya. 
PAK1 was from Dr. Yi Wu.
In vitro fluorometry assay
Fluorometry assays were performed following published protocols 5. Briefly, in experiments 
in which the biosensor was co-transfected with negative regulators (GDI or GAP), the ratio 
of biosensor to regulator cDNA was 1/4. In experiments using GEFs with excess GDI, the 
DNA ratio for biosensor/RhoGDI/GEF was 1/4/1–5. In experiments with GEFs and GAP 
without excess GDI, the ratio of biosensor to regulator cDNA was 1/4. In experiments with 
effectors, the biosensor/effector DNA ratio was 1/4. The total amount of transfected DNA 
was kept to 4–5μg per well in a 6-well plate, using a total fluid volume of 2 ml per well. 
HEK 293T (ATCC) cells were plated in 6 well plates overnight at 1.25×10–6 cells per well. 
DNA was transfected using the Lipofectamine 2000 reagent (Invitrogen) following the 
manufacturer's protocols. 48hrs post-transfection, cells were trypsinized, detached, and 
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suspended in cold PBS. The cell suspension was immediately measured in a Fluorolog 
SPEX MF2 spectrofluorometer (Horiba Jobin Yvon). Emission was measured from 450~600 
nm, with 433 nm excitation. Emission counts at 525 nm were then divided by the emission 
counts at 470 nm to normalize for biosensor concentration.
shRNA-knockdown/rescue
The shRNA for GDI was as designed previously 15. cDNA encoding the shRNA (and a 
scrambled control) 5’-
TGCGCGCTATGTAGGATTCGTTCAAGAGACGAATCCTACATAGCGCGCTTTTTTC-3
’) was cloned into pLL5.5CMV 37 at HpaI/XhoI sites. Lentivirus incorporating the shRNA 
expression construct was produced using the GP2-293 packaging cell line together with 
pVSVg envelope system following the manufacturer's protocols (Clontech). In order to 
produce an efficient knockdown and rescue using the shRNA resistant versions of the 
wildtype and mutant GDI 15, a retroviral expression system was used to stably incorporate 
the Y156E and Y156F mutant versions of the GDI using the pQXIH system (Clontech) and 
selected with 100μg/ml hygromycin B. In the endogenous wildtype GDI background, stable 
expressions of these mutant versions of GDI did not appear to affect cell health. For the 
production of wildtype GDI KD/rescue, we utilized a pRetro-X-Hygro backbone (Clontech) 
to suppress the expression of the wildtype GDI using the tet-OFF system. MEF stably 
incorporating the GDI biosensor were plated onto tissue culture dishes plated with poly-L-
lysine and allowed to induce the expression of the biosensor for 48hrs through the removal 
of doxycycline. Lentivirus containing the shRNA for GDI was applied and, for most 
effective KD efficiency, the cells were allowed to recover for 96hrs prior to imaging 
experiments.
Microscopy and live-cell imaging
To quantify two biosensor activities in the same cell, we combined the GC-FLARE 
biosensor, based on CFP-YFP FRET, with a modification of the MeroCBD Cdc42 biosensor 
published earlier 4,6. The wavelengths of MeroCBD were altered to produce fluorescence 
orthogonal to that of G/C FLARE by using a version of the far-red dye, Atto-700-NHS 
(Sigma) with improved photostability. We also removed the EGFP from MeroCBD because 
of spectral overlap between EGFP and the CFP-YFP FRET pair in G/C FLARE. Removal of 
the GFP greatly reduced the water solubility of the dye-labeled CBD domain, so maltose 
binding protein (MBP) was attached to the C-terminus of CBD using a GSGSGS linker. The 
N-terminal amine of CBD-MBP was labelled site-specifically with Atto-700-NHS 
succinimidyl ester at pH 5.6. Modification of the original MeroCBD biosensor was 
prompted by two factors: 1) photobleacing of the original Alexa750 (Invitrogen) dye was 
very fast and 2) our multi-channel imaging system 38 used a laser-based autofocus system 
that precluded the use of wavelengths above 750nm.
MEF/3T3 cells induced to express the GDI biosensor by removal of tetracycline were plated 
directly on glass coverslips for five to six hours prior to microinjection and imaging. 
Coverslips were cleaned by ultrasonication followed by soaking in 70% ethanol prior to use 
in these studies. Modified MeroCBD was microinjected and cells were allowed to recover 
for 30 minutes before imaging. Cells were imaged in Ham's F-12K medium without phenol 
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red (Biosource) sparged with Argon to remove dissolved oxygen, and supplemented with 
3% fetal bovine serum, 10mM HEPES, 10 μg/ml Oxyfluor reagent (Oxyrase Inc.) and 
10mM dl-lactate. Cells were imaged at 37°C in a closed chamber. Images were obtained 
using a 40× 1.3 N/A PLANAPO UIS2 DIC objective (Olympus) and an IX81 ZDC inverted 
microscope (Olympus) with a beam splitter for simultaneous acquisitions of both FRET and 
CFP channels using two CoolsnapESII CCD cameras (Roper Photometrics). For the 
acquisitions of mero87 and Atto-700 fluorescence, a CoolsnapHQ2 (Roper Photometrics) 
camera was attached to the bottom port of the microscope via a filterwheel that changed the 
emission filters between mero87 and Atto700 emission wavelengths during acquisition at 
each time point. Metamorph software version 7.1.7 was used to control the microscope and 
acquire image sets at 10s time intervals The imaging system has been described in detail 38.
Image processing and analysis
Metamorph ver 7.1.7 was used to perform image processing and data analysis. All images 
were flat-field corrected and background subtracted 39. Both CFP/FRET and mero87/
Atto700 images were intensity thresholded to generate a binary mask with a value of zero 
outside the cell and a value of one inside the cell. Shading-corrected and background-
subtracted images were multiplied by the corresponding binary masks to set areas outside 
the cell uniformly to zero, to minimize noise and other artefacts. These images were then 
aligned computationally, using previously described procedures 40,41 to ascertain optimal 
registration with subpixel accuracy. Masked FRET or mero87 images were divided by the 
masked CFP or Atto700 images respectively, to yield a ratio reflecting GDI-GTPase 
interaction or Cdc42 activation. A linear pseudocolor lookup table was applied to the 
ratiometric images. In every data set, raw fluorescent images were carefully inspected to 
verify that all portions used to create the ratio image had sufficient signal/noise ratio. This 
was especially important in thin parts of the cell where fluorescence was low. In time-lapse 
experiments, various fluorophores bleached at different rates. The ratio was corrected for 
bleaching using a previously published method 42.
Cell edge tracking
Cell edges were derived from the binary mask mentioned above. The changing position of 
edges over time was tracked computationally using previously described software written in 
Matlab (Mathworks) 43. Rates of protrusion and retraction (velocity maps) were calculated 
using the finite differences of positions in consecutive frame triplets at T–1, T, and T+1.
Definition of sampling windows
Due to the subcellular heterogeneity of protrusion and retraction states, relationships 
between GDI–Cdc42 binding, Cdc42 activation, and cell edge motion had to be identified 
locally. As in previous work 4 we determined small probing windows of 1–2 microns width 
and 0.9 micron depths that moved with the edge (see Supplementary Fig. 6). The width of 
the windows was set in agreement with the FWHM (full width at half maximum) of ~4 
microns of the average spatial autocorrelation of edge velocity fluctuations along the cell 
edge; i.e. along the cell edge signaling and motion activity are sampled at Nyquist or better. 
The depth of the windows was set based on our previous studies revealing changes in Cdc42 
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signaling away from the cell edge over distances as short as 1 micron 4,6. Windows were 
propagated over time such that they maintained a fixed geometric relationship with a 
particular location at the cell edge. For windows at the cell edge protrusion/retraction vectors 
were averaged to report a mean velocity over the edge segment covered by a particular 
window. For all windows the values of the normalized FRET values were averaged over all 
pixels contained by a particular window. This allowed the construction of space-time activity 
maps that were cell-shape invariant and amenable to statistical analysis of the temporal 
relations between the two signaling activities and edge motion.
Correlation analysis
Temporal cross-correlations between two variables sampled in a particular window were 
determined by Pearson's correlation coefficient. For windows located away from the cell 
edge correlations between signaling activity and edge motion were calculated by extracting 
the time series of the former with the time series of the edge motion measured in the closest 
window located at the cell periphery. The correlation between two variables at a particular 
distance from the edge was obtained by averaging the correlation function over all sampling 
windows at the set distance.
To investigate the cell-to-cell heterogeneity of the cross-correlation a common cross-
correlation was estimated by computing a smoothing spline for the ensemble of average 
correlation data from different cells. The variance of the smoothing spline approximation 
and hence of the location of the maximum correlation was calculated by a non-parametric 
bootstrap method 44,45: From the residuals of the approximated spline 2000 bootstrap 
samples were taken to calculate local variation of the spline about the mean, variation in 
maximum correlation coefficient, and variation in location of the maximum correlation (time 
lag). The 95% confidence interval for the estimated common cross-correlation was obtained 
in each location as the interval containing 95% of the bootstrapped spline samples.
Representing the biosensor using crystal structure data
The hypothetical structure of the GDI.Cdc42 FLARE biosensor in Supplementary Figure 4 
was constructed using the crystal structures of Cdc42 in complex with GAP(pdb id: 2NGR), 
GEF(pdb id: 1KZ7), and GDI(pdb id: 1DOA). PyMOL software v1.7.4.4 (Schrödinger LLC) 
was used to visualize these structures and to edit the relative locations of FPs. We assumed 
cp49Venus and Cerulean would form a dimer similar to GFP wild type dimer, which was 
used as a template (pdb id: 2B3Q) to show the dimer of cp49Venus and Cerulean in the 
high-FRET state.
Statistical analysis
All p-values were determined using a Student t-test. No statistical methods were used to pre-
determine the sample size, no vertebrate animals were involved. No randomizations were 
used. The investigators were not blinded to allocation during experiments and outcome 
assessment. Statistical tests used are stated on every figure legend with p-values as 
appropriate. Data distribution should meet the normal distribution requirements. No estimate 
of variation. No pre-established criteria were used to determine data inclusion/exclusion.
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Fig.1. 
Design and validation of GDI.Cdc42 FLARE, a genetically encoded biosensor that reports 
localization of Cdc42-GDI complexes. a, The FRET of a “binding antenna” on Cdc42 is 
altered when Cdc42 binds endogenous GDI. b, A representative, normalized emission 
spectra of GDI.Cdc42 FLARE in HEK 293T cells (excitation 433 nm; normalized at the 474 
nm emission peak). Solid line, wild-type biosensor; dash-dotted line, wild-type biosensor 
plus excess GDI. c, Normalized FRET/CFP emission ratios of GDI.Cdc42 FLARE mutants, 
expressed with and without excess GDI. d, Normalized FRET/CFP emission ratios of 
wildtype GDI.Cdc42 FLARE with co-expressed GEFs or GAPs, in the presence or absence 
of excess GDI. Green bars indicate Cdc42-interacting GEFs. Blue bars indicate GEFs that 
do not interact with Cdc42. For (b)–(d), Results are the mean of three independent 
measurements. Error bars represent ±SEM.
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Fig.2. 
Cdc42-GDI complex localization in living cells. a, MEFs expressing the GDI.Cdc42 
FLARE biosensor. Note the relatively uniform distribution of Cdc42-GDI complex except at 
the cell edges. b, Localization of GDI-Cdc42 at a cell edge undergoing protrusion/retraction 
cycles. Below each image is the fluorescence ratio measured along the white line shown in 
the first image GDI-Cdc42 complex is reduced at the cell edge during protrusion and 
increased during retraction. c, TOP: Correlation of Cdc42-GDI localization and edge 
velocity, measured using the GDI.Cdc42 FLARE biosensor. Correlation curves are 
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computed from n = 704 individual windows in 8 cells (see Supplementary Fig. 6). 
MIDDLE: Correlation of Cdc42 activity and edge velocity measured in the wild-type MEFs 
using the MeroCBD biosensor. Correlation curves are computed from n = 420 individual 
windows in 7 cells. BOTTOM: Cross-correlation of the correlation curves shown in the top 
and middle rows. Panels (a) and (b) pseudocolor range: 1.0 = black; 1.4 = red. White bar 
indicates 10 μm.
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Fig.3. 
Relationship between Cdc42 activation and GDI-Cdc42 localization monitored in the same 
cell. a, MEFs expressing the T35S mutant version of the GDI.Cdc42 FLARE biosensor and 
injected with the modified meroCBD biosensor. Left column: Cdc42 activity, Right Column: 
GDI-Cdc42 localization. (Pseudocolor scales: for Cdc42, Black=1.0, Red=7.46 (top cell), 
2.82 (bottom cell); for GDI-Cdc42: Black=1.0, Red=1.51 (top cell), 1.97 (bottom cell). Bar 
= 20 μm). b, Cdc42 activation (TOP) and Cdc42-GDI localization (MIDDLE) in the same 
cell over time. (Pseudocolor scales: Cdc42 1.0–2.3, Cdc42-GDI 1.0–1.53. Bar = 5 μm). 
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BOTTOM: Profile of Cdc42 activation (blue) and GDI-Cdc42 (red) along the line shown in 
the first panel of the top row. c, Correlation of Cdc42-GDI and edge velocity, measured 
using the T35S mutant of the GDI.Cdc42 FLARE biosensor. Correlation curves are 
computed from n = 886 individual windows in 7 cells. d, Correlation of Cdc42 activity and 
Cdc42-GDI monitored in the same cell, using the T35S mutant version of GDI.Cdc42 
FLARE and the modified meroCBD. Correlation curves are computed from n = 420 
individual windows in 7 cells.
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Fig.4. 
Src-mediated phosphorylation of GDI at Y156 regulates the coordination of Cdc42-GDI 
localization and Cdc42 activity in regions close to the edge. a, A phosphorylation-deficient 
mutant of GDI (Y156F) had no effect on the timing of Cdc42 activation or modulation of 
GDI-Cdc42 localization. TOP: Correlation of Cdc42-GDI and edge velocity, using the T35S 
mutant of the GDI.Cdc42 FLARE biosensor expressed in cells containing Y156F GDI. 
Correlation curves are computed from n = 902 individual windows in 11 cells. BOTTOM: 
Correlation of Cdc42 activity and edge velocity using the MeroCBD biosensor in cells 
containing Y156F GDI. Correlation curves are computed from n = 373 individual windows 
from 5 cells. b, A phosphomimetic mutant of GDI (Y156E) produced positive correlation 
with edge velocity at negative time lags (i.e. after protrusion onset) similar to those of the 
correlation maxima of Cdc42 activity with edge velocity in regions close to the edge (0–1.8 
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μm; Black arrows). TOP: Cross-correlation of Cdc42-GDI and edge velocity using the T35S 
mutant of the GDI.Cdc42 FLARE biosensor expressed in cells containing the Y156E mutant 
GDI. Correlation curves are computed from n = 979 individual windows from 11 cells. 
Black arrows in regions 0–1.8 μm from the edge indicate the appearance of a positive cross 
correlation peak in GDI-Cdc42 complex localization. BOTTOM: Cross-correlation of 
Cdc42 activity and edge velocity, using the MeroCBD biosensor in cells containing GDI 
Y156E. Correlation curves are computed from n = 491 individual windows in 4 cells.
Hodgson et al. Page 24
Nat Chem Biol. Author manuscript; available in PMC 2017 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
